Binodenoson

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBinodenoson
Drug Alias Namebinodenosonum倍诺生Binodisine比诺迪松比诺地松 +[10] 
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionAdenosine A2a receptor agonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAderis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG